Blood-born tissue factor in cardiovascular disease: where are we now?

被引:0
|
作者
Vincenzo Toschi
机构
[1] A.O. Ospedale San Carlo Borromeo,Department of Hematology and Blood Transfusion, Thrombosis Center
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 5
页数:2
相关论文
共 50 条
  • [11] Fabry disease: where are we now?
    Turkmen, K.
    Baloglu, I.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (11) : 2113 - 2122
  • [12] Where to now in cardiovascular disease prevention
    Najam, Osman
    Ray, Kausik K.
    ATHEROSCLEROSIS, 2016, 251 : 483 - 489
  • [13] Blood-Based Biomarkers in Alzheimer Disease: Where Are We Now and Where Have We to Go? reply
    Bray, Benjamin
    Hoffman, Alex
    Tyrrell, Pippa
    Rudd, Anthony
    JAMA NEUROLOGY, 2013, 70 (01) : 133 - 134
  • [14] Probiotics and Liver Disease Where Are We Now and Where Are We Going?
    Elzouki, Abdel-Naser
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 : S188 - S190
  • [15] Ebola virus disease: where are we now and where do we go?
    Brown, Colin S.
    Cropley, Ian M.
    POSTGRADUATE MEDICAL JOURNAL, 2014, 90 (1069) : 610 - 612
  • [16] Bone tissue engineering for osteointegration: Where are we now?
    Aykora, Damla
    Uzun, Metehan
    POLYMER BULLETIN, 2024, 81 (10) : 8595 - 8605
  • [17] LUNG-DISEASE - WHERE ARE WE NOW
    PETTY, TL
    CHEST, 1976, 70 (06) : 695 - 696
  • [18] Multicentric Castleman disease: Where are we now?
    Wang, Hao-Wei
    Pittaluga, Stefania
    Jaffe, Elaine S.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2016, 33 (05) : 294 - 306
  • [19] Gonadotrophin surge attenuating factor: Where are we now?
    Balen, AH
    CLINICAL ENDOCRINOLOGY, 1996, 44 (02) : 177 - 180
  • [20] Homologous blood transfusion and doping: Where are we now?
    Marchand, Alexandre
    Ericsson, Magnus
    DRUG TESTING AND ANALYSIS, 2024, 16 (12) : 1479 - 1486